Loring Wolcott & Coolidge Fiduciary Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.87M Sell
81,469
-792
-1% -$70.6K 0.07% 80
2025
Q4
$7.05M Sell
82,261
-350
-0.4% -$27.4K 0.06% 79
2025
Q3
$6.48M Buy
82,611
+17,485
+27% +$1.49M 0.06% 79
2025
Q2
$5.92M Sell
65,126
-882
-1% -$80.5K 0.05% 84
2025
Q1
$6.2M Sell
66,008
-56,864
-46% -$5.09M 0.06% 79
2024
Q4
$11.2M Sell
122,872
-1,602
-1% -$153K 0.1% 70
2024
Q3
$12.4M Buy
124,474
+52,860
+74% +$5.39M 0.11% 67
2024
Q2
$6.98M Sell
71,614
-645
-0.9% -$59.5K 0.06% 78
2024
Q1
$6.38M Sell
72,259
-2,435
-3% -$206K 0.06% 77
2023
Q4
$6.29M Sell
74,694
-9,799
-12% -$737K 0.06% 75
2023
Q3
$6.32M Sell
84,493
-11,718
-12% -$876K 0.07% 75
2023
Q2
$7.41M Sell
96,211
-3,979
-4% -$308K 0.08% 72
2023
Q1
$7.53M Sell
100,190
-1,934
-2% -$144K 0.09% 71
2022
Q4
$8.05M Buy
102,124
+437
+0.4% +$32.8K 0.1% 71
2022
Q3
$7.14M Sell
101,687
-2,119
-2% -$166K 0.09% 71
2022
Q2
$8.32M Sell
103,806
-8,617
-8% -$674K 0.1% 69
2022
Q1
$8.53M Sell
112,423
-14,288
-11% -$1.13M 0.09% 72
2021
Q4
$10.8M Sell
126,711
-33,711
-21% -$2.63M 0.1% 68
2021
Q3
$12.1M Sell
160,422
-53,479
-25% -$4.25M 0.12% 64
2021
Q2
$17.4M Sell
213,901
-47,301
-18% -$3.87M 0.18% 62
2021
Q1
$20.6M Sell
261,202
-110,476
-30% -$8.66M 0.23% 58
2020
Q4
$31.8M Sell
371,678
-24,525
-6% -$2.03M 0.36% 52
2020
Q3
$30.6M Sell
396,203
-11,155
-3% -$851K 0.38% 50
2020
Q2
$29.8M Sell
407,358
-4,974
-1% -$353K 0.41% 47
2020
Q1
$27.4M Sell
412,332
-97,323
-19% -$6.86M 0.46% 41
2019
Q4
$35.1M Sell
509,655
-42,823
-8% -$2.92M 0.47% 45
2019
Q3
$40.6M Sell
552,478
-33,579
-6% -$2.44M 0.59% 42
2019
Q2
$42M Sell
586,057
-173,310
-23% -$12.3M 0.61% 42
2019
Q1
$52M Sell
759,367
-196,651
-21% -$12.7M 0.79% 36
2018
Q4
$56.9M Sell
956,018
-222,878
-19% -$13.9M 1.03% 31
2018
Q3
$78.9M Sell
1,178,896
-132,533
-10% -$8.83M 1.25% 26
2018
Q2
$85M Sell
1,311,429
-86,005
-6% -$5.63M 1.48% 23
2018
Q1
$100M Sell
1,397,434
-101,392
-7% -$7.3M 1.82% 20
2017
Q4
$113M Sell
1,498,826
-26,207
-2% -$1.91M 2.08% 18
2017
Q3
$111M Sell
1,525,033
-7,259
-0.5% -$523K 2.15% 17
2017
Q2
$111M Sell
1,532,292
-34,701
-2% -$2.58M 2.2% 14
2017
Q1
$115M Buy
1,566,993
+2,097
+0.1% +$147K 2.4% 12
2016
Q4
$102M Sell
1,564,896
-6,636
-0.4% -$455K 2.28% 13
2016
Q3
$117M Sell
1,571,532
-10,242
-0.6% -$757K 2.66% 11
2016
Q2
$116M Sell
1,581,774
-20,788
-1% -$1.48M 2.66% 11
2016
Q1
$113M Buy
1,602,562
+10,596
+0.7% +$705K 2.67% 11
2015
Q4
$106M Buy
1,591,966
+56,810
+4% +$3.78M 2.63% 10
2015
Q3
$100M Hold
1,535,156
2.56% 10
2015
Q2
$100M Sell
1,535,156
-17,487
-1% -$1.19M 2.56% 10
2015
Q1
$108M Buy
1,552,643
+19,971
+1% +$1.38M 2.72% 9
2014
Q4
$106M Sell
1,532,672
-11,992
-0.8% -$810K 2.72% 10
2014
Q3
$101M Sell
1,544,664
-7,345
-0.5% -$484K 2.73% 9
2014
Q2
$106M Sell
1,552,009
-18,925
-1% -$1.27M 2.86% 9
2014
Q1
$102M Sell
1,570,934
-30,883
-2% -$1.95M 2.79% 8
2013
Q4
$104M Sell
1,601,817
-12,684
-0.8% -$812K 2.88% 8
2013
Q3
$95.7M Sell
1,614,501
-7,929
-0.5% -$470K 2.92% 8
2013
Q2
$92.9M Buy
+1,622,430
New +$96.3M 2.91% 7

Other funds holding CL

Loring Wolcott & Coolidge Fiduciary Advisors's CL Position: Q1 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors reduced its Colgate-Palmolive (CL) stake by 0.96% in Q1 2026, selling an estimated $70.6K and leaving 81,469 shares worth $6.87M. The position accounts for 0.07% of the portfolio, ranked #80.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $117M in Q3 2016. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 81,469 shares of Colgate-Palmolive worth $6.87M as of Q1 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 792 Colgate-Palmolive shares in Q1 2026, an estimated $70.6K.
  • Colgate-Palmolive made up 0.07% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q1 2026, its #80 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Colgate-Palmolive position peaked at $117M in Q3 2016.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.